Sanofi SA (NASDAQ:SNY)
| 38.04 Delayed Data As of Sep 30 |  +0.05 / +0.13%Today’s Change | 36.91 Today|||52-Week Range 58.10 | -24.07% Year-to-Date |
Latest SNY News | Press Releases
Today’s Trading
| Previous close | 37.99 |
| Today’s open | 38.26 |
| Day’s range | 38.03 - 38.57 |
| Volume | 91,467 |
| Average volume (3 months) | 2,926,725 |
| Market cap | $96.0B |
Data as of 4:01pm ET, 09/30/2022
Growth & Valuation
| Earnings growth (last year) | -47.56% |
| Earnings growth (this year) | +8.47% |
| Earnings growth (next 5 years) | +8.00% |
| Revenue growth (last year) | +8.63% |
| P/E ratio | 14.7 |
| Price/Sales | 2.82 |
| Price/Book | 1.23 |
Competitors
| ---- | ||
| REGNRegeneron Pharmaceut... | -2.22 | -0.32% |
| VRTXVertex Pharmaceutica... | -3.46 | -1.18% |
| ZTSZoetis Inc | -2.60 | -1.72% |
Data as of 4:02pm ET, 09/30/2022
Financials
| Next reporting date | October 28, 2022 |
| EPS forecast (this quarter) | $1.30 |
| Annual revenue (last year) | $44.6B |
| Annual profit (last year) | $7.4B |
| Net profit margin | 16.48% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Paris, Ile-de-france |
Forecasts
